Owl Creek Asset Management’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Owl Creek Asset Management’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-414,000	Closed	-$7.91K	–	199
2023 Q1	$7.91K	Hold	414,000	–	–	﹤0.01%	170
2022 Q4	$61.6K	Hold	414,000	–	–	﹤0.01%	145
2022 Q3	$70K	Hold	414,000	–	–	﹤0.01%	170
2022 Q2	$52K	Hold	414,000	–	–	﹤0.01%	225
2022 Q1	$328K	Hold	414,000	–	–	0.01%	179
2021 Q4	$248K	Buy	+414,000	New	+$420K	0.02%	251

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Owl Creek Asset Management's PEARW Position: Q2 2023 in Review

Owl Creek Asset Management sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 414,000 shares — an estimated $7.91K sold.

Owl Creek Asset Management first reported a position in PEARW in Q4 2021 and held it in 6 quarters. The position peaked at $328K in Q1 2022. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Owl Creek Asset Management reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Owl Creek Asset Management sold 414,000 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $7.91K.
Owl Creek Asset Management first reported a position in Pear Therapeutics, Inc. Warrant in Q4 2021 and held it in 6 quarters.
Owl Creek Asset Management's Pear Therapeutics, Inc. Warrant position peaked at $328K in Q1 2022.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Owl Creek Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.